Mass spectrometry confirms peptide identity by weighing the molecule: the instrument measures the mass-to-charge ratio of ionized peptide, software reconstructs the molecular mass, and that observed mass is compared with the mass calculated from the intended sequence. Agreement within the method's tolerance — typically a fraction of a dalton for research-scale QC — is the evidence that the vial contains the molecule on the label. HPLC cannot provide this: a chromatogram says how homogeneous the material is, never what it is. On a certificate of analysis, mass spectrometry and HPLC therefore answer complementary questions — identity and purity — and this guide covers the identity half.
How a peptide gets weighed
A mass spectrometer needs the peptide as gas-phase ions. Two ionization methods dominate peptide QC:
- ESI (electrospray ionization). The dissolved peptide is sprayed through a charged capillary, producing ions carrying one, two, three or more protons. ESI couples directly to HPLC (LC-MS), which is why it is the routine choice for release testing.
- MALDI-TOF. The peptide is co-crystallized with a UV-absorbing matrix and desorbed by laser pulses, mostly as singly charged ions, with mass measured by time-of-flight. Fast and tolerant of salts, common for synthesis-lab checks.
Either way, the readout is a spectrum of mass-to-charge (m/z) peaks from which the neutral molecular mass is calculated.
Reading an ESI spectrum: charge states
An ESI spectrum of one pure peptide usually shows several peaks, and this confuses first-time readers into seeing "impurities". They are charge states of the same molecule: [M+H]⁺, [M+2H]²⁺, [M+3H]³⁺. The m/z of each is (M + n×1.007) ÷ n. Worked example with BPC-157 (average mass 1419.55): the singly charged ion appears near m/z 1420.6 and the doubly charged near 710.8. For a large peptide like semaglutide (4113.58 g/mol), high charge states dominate — [M+3H]³⁺ near 1372.2 and [M+4H]⁴⁺ near 1029.4 — and deconvolution software collapses the series back to one neutral mass. If two peaks in a spectrum imply the same deconvoluted mass, they are one species.
Theoretical mass: monoisotopic vs average
The "calculated" mass on a COA comes from the molecular formula, and there are two conventions. Monoisotopic mass sums the lightest isotope of each element and matches the first peak of a resolved isotope cluster — the natural choice on high-resolution instruments. Average mass weights isotopes by natural abundance and matches the centroid of an unresolved cluster. For a ~1400 Da peptide they differ by roughly 1 Da, so knowing which convention a document uses prevents false alarms. The formula itself derives from the sequence, including modifications — how acetylation, amidation and fragment numbering are written is covered in how to read a peptide sequence.
Diagnostic mass shifts worth memorizing
| Observed − theoretical | Likely cause | Notes |
|---|---|---|
| +16 Da | Oxidation (commonly methionine) | See methionine oxidation; a storage as well as synthesis issue |
| +42 Da | Unintended acetylation | Or intended — acetylated peptides like TB-500 (Ac-LKKTETQ) include it in the theoretical mass |
| −18 Da | Dehydration / aspartimide formation | Common at Asp-Gly motifs |
| +1 Da | Deamidation (Asn→Asp, Gln→Glu) | Subtle; needs good resolution |
| − one residue mass | Deletion sequence | e.g. −57 (Gly), −71 (Ala), −87 (Ser) missing |
| +80 Da | Phosphorylation or sulfation | Rare in catalog peptides unless specified |
| −0.98 Da vs free acid | C-terminal amidation | Amide (−NH2) vs acid (−OH) termini differ by ~1 Da |
These shifts make MS more than a pass/fail check: the direction and size of a discrepancy usually names the culprit.
What MS does and does not establish
- Establishes: that the dominant species has the mass of the intended molecule, including its modifications and, with LC-MS, that the main HPLC peak carries that mass.
- Does not establish by intact mass alone: sequence order. Two peptides with the same composition in different order weigh the same; distinguishing them requires fragmentation (MS/MS), which is reserved for characterization rather than routine lot QC.
- Does not establish: quantity or purity percentages (ionization efficiency differs between species), water and counter-ion content, or biological activity. Purity remains HPLC's job — see HPLC purity explained — and quantity questions belong to net peptide content and molar arithmetic.
Using MS data as a buyer
- Find both numbers. A COA should state theoretical and observed mass explicitly. "Conforms" with no numbers is a weak certificate.
- Check the agreement and the convention. Sub-dalton agreement using a stated monoisotopic or average convention is the expected standard.
- Check modifications are included. An acetylated, amidated or lipidated peptide's theoretical mass must reflect the modification; a COA quoting the unmodified backbone mass for a modified product is internally inconsistent.
- Match the lot, as with every COA element — the lot number links spectrum to vial, and independent re-testing per third-party testing explained is the strongest confirmation available to a research buyer.
Every peptide in the lyophilized vial catalog here ships with MS identity confirmation alongside ≥99% HPLC purity on the lot-matched COA — the two halves of quality control, read together. For the diligence framework around them, start with the vendor checklist.